SCHEMBL8722646

SCHEMBL8722646

CC(C)(CO)n1cnc2c[n+]([O-])c3ccccc3c21

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 1/20 0.35
RAB9A P51151 1/20 0.32
DPP4 P27487 1/20 0.32
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8721699 0.85 HPGD (0.34) TLR7RAB9A
SCHEMBL8722647 0.84 RAB9A (0.33) TLR7RAB9A
SCHEMBL10733260 0.78 DPP4 (0.36) TLR7DPP4
SCHEMBL9602275 0.78 DPP4 (0.41) TLR7RAB9ADPP4CYP1A2
SCHEMBL10739313 0.78 TLR7 (0.49) TLR7
SCHEMBL8721690 0.75 CYP1A2 (0.40) TLR7CYP1A2
SCHEMBL10727327 0.75 TLR7 (0.36) TLR7RAB9A
SCHEMBL1335102 0.74 CSNK2A2 (0.37) DPP4CYP1A2
SCHEMBL10588936 0.73 ALDH1A1 (0.41) RAB9A
SCHEMBL3192664 0.72 TLR7 (0.47) TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5756747-A 1H-imidazo 4,5-c!quinolin-4-amines RIKER LABORATORIES, INC. (US) 1998-05-26 US disclosed
EP-0385630-B1 1H-imidazo(4,5-c)Quinolin-4-amines as antivirals RIKER LABORATORIES INC (US) 1996-11-27 EP disclosed
EP-0389302-B1 Olefinic 1H-imidazo [4,5-c]quinolin-4-amines RIKER LABORATORIES INC (US) 1994-08-31 EP disclosed
US-5037986-A Olefinic 1H-imidazo[4,5-c]quinolin-4-amines MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-08-06 US disclosed
EP-0389302-A1 Olefinic 1H-imidazo [4,5-c]quinolin-4-amines RIKER LABORATORIES, INC. (US) 1990-09-26 EP disclosed
EP-0385630-A2 1H-imidazo(4,5-c)Quinolin-4-amines as antivirals RIKER LABORATORIES, INC. (US) 1990-09-05 EP disclosed